M. Allen Northrup Frsc

M. Allen Northrup PhD FRSC is a prominent figure in the fields of biomedical engineering and diagnostics, with extensive experience in both entrepreneurial ventures and consulting. Currently serving as a Board Member and Founder of MIODx, as well as CEO of IQPath Technologies, Inc., M. Allen Northrup has developed proprietary cancer biomarker diagnostics that enhance prognostic capabilities. Northrup Consulting Group, founded in 2011, focuses on intellectual property matters, particularly in microfluidics and biotech start-ups. M. Allen Northrup has also been involved with several scientific advisory boards, including Fluigent and Pharmafluidics. Previous leadership roles include CEO at Microfluidic Systems and co-founder at Cepheid, contributing significantly to funded research and development efforts in the biotech sector. Educational credentials include a PhD in Biomedical/Medical Engineering from the University of California, Davis, and a Master's degree in Zoology/Animal Biology from Humboldt State University.